Substance use among street-involved youth in Canada: Pan-Canadian findings from the People with Lived and Living Experience Survey

Download the entire report
(PDF format, 740 KB)

Organization: Health Canada

Date published: 2024

Resources

Due to the sensitive nature of substance use and the drug toxicity crisis, certain parts of this report may cause emotional distress. Mental health supports are available:

If you or someone you love is struggling with substance use, help is available:

Introduction

Studies have shown that in Canada, homelessness among youth is associated with poor nutrition, victimization, higher-risk substance use, and limited access to health and social servicesFootnote 1Footnote 2Footnote 3Footnote 4Footnote 5. This often leads to harmful effects on health, isolation among youth, and higher rates of substance use and mental health problemsFootnote 6.

Although street-involved youth are at higher risk of substance-related harms, they are under-represented in survey data on substance use. In response, Health Canada developed a targeted survey called the People with Lived and Living Experience Survey (PWLLES) to examine substance use and related harms among street-involved youth, with input from a peer researcher and other stakeholders. This report focuses on quantitative findings from the PWLLES, which collected responses from September 2021 to February 2023 from youth aged 14-24 years who were 1) experiencing homelessness, unstable housing, spent most of their time in the streets, and/or accessed services for street involved youth, and 2) who had used alcohol, tobacco, cannabis, or other drugs in the past year.

Key findings

Demographics and social determinants of health

There were 442 participants from 16 sentinel sites across 9 Canadian cities that completed the survey. Ontario (37.8%) and the Prairies (25.1%) accounted for the greatest proportion of participants. The Atlantic region had low participation (less than 5.0%), and no sentinel sites were engaged in the Territories. At the city level, Windsor (22.9%), Montreal (17.2%), and Vancouver (15.8%) had the greatest proportion of participants (Figure 1).

Figure 1: Number of PWLLES participants by city, September 2021 to February 2023 (n = 442)
Figure 1. Text version below.
Figure 1 - Text description
City Number of participants (Number of sites) Percentage of participants (%) Total
Windsor 101 (2) 22.9 442
Montreal 76 (2) 17.2
Vancouver 70 (3) 15.8
Toronto 66 (3) 14.9
Edmonton 38 (1) 8.6
Winnipeg 38 (1) 8.6
Calgary 29 (2) 6.6
Halifax 18 (1) 4.1
Saskatoon 6 (1) 1.4

Note: The size of the circle on each city is scaled proportionally to the number of PWLLES participants in that city.

The average age of all participants was 20.7 years (standard deviation [SD] = 2.7 years). Most participants (80.1%) were above the legal age for alcohol consumption in their province. The majority identified as cisgender (86.9%), with slightly more cisgender males (46.4%) than cisgender females (40.5%) [Table 1]. Just over half reported their sexual orientation as heterosexual or straight (55.4%), followed by bisexual or pansexual (17.9%). Approximately 1 quarter of participants (26.0%) identified as Indigenous, and of these, 74.8% identified as First Nations. One (1) third of respondents (33.9%) identified as visible minorities, and of these, the most commonly reported racialized identities were Black (38.0%); Other race, including multiracial identity (18.7%); and Latino (13.3%).

Most participants reported currently living in a shelter or refuge (29.1%), or a rented house or apartment (alone or shared) [28.9%]. Approximately 3 quarters of participants (73.3%) stated that they were not currently attending a school, college, CEGEP or university. Most participants (70.4%) were unemployed, while 24.2% reported currently having full-time, part-time, or seasonal employment.

Table 1: Demographic and social determinants of health of participants in the PWLLES, September 2021 to February 2023 (n = 442)
Demographic characteristics Number of participants Percentage of participants (%) Total
Gender identity
Cisgender male 205 46.4 442
Cisgender female 179 40.5
Non-binary 29 6.6
Transgender female 12 2.7
Transgender male 11 2.5
Prefer not to answer 6 1.4
Sexual orientation
Heterosexual/straight 245 55.4 442
Bisexual or pansexual 79 17.9
Gay or lesbian 35 7.9
Sexual orientation, n.e.c. 24 5.4
Prefer not to answer 59 13.3
Indigenous identity
Not Indigenous 293 66.3 442
IndigenousFootnote * 115 26.0
Prefer not to answer or do not know 34 7.7
Population Group
Visible minority 150 33.9 442
Not a visible minority 258 58.4
Prefer not to answer or do not know 34 7.7
Current living situationFootnote
Shelter/refuge 120 29.1 412
Rented house/apartment (alone/shared) 119 28.9
Parents'/carers' family home 61 14.8
No fixed address/couch surfing/staying with friends 50 12.1
Boarding house/hostel/single room occupancy hotel (SRO) 30 7.3
Other 32 7.8
Footnote ‡

'Prefer not to answer' was excluded from the denominator.

Return to footnote referrer

Footnote *

74.8% of Indigenous participants identified as First Nations. Métis, Inuit, and Prefer not to answer are not reported due to small cells and risk of re-identification.
n.e.c. not elsewhere classified

Return to footnote * referrer

Substance use trends

Among participants who had ever used each respective substance, the most used substances in the past 30 days were cannabis (85.0%), cigarettes (81.2%), alcohol (80.3%), illegal drugs (57.0%), and vaping nicotine (55.7%) [Table 2].

Table 2: Past 30-day substance use among PWLLES participants, September 2021 to February 2023 (n = 442)
Prevalence of substance use Number of participants Percentage of participants (%) Total
CannabisFootnote 328 85.0 386
Smoking cigarettesFootnote 290 81.2 357
Alcohol (more than a sip)Footnote 331 80.3 412
Illegal drugsFootnote 150 57.0 263
Vaping nicotineFootnote 244 55.7 438
StimulantsFootnote 83 46.1 180
Sedatives or tranquilizersFootnote 61 39.1 156
Opioid or opioid-containing pain-relieversFootnote § 75 38.9 193
Footnote ‡

'Prefer not to answer' was excluded from the denominator.

Return to footnote referrer

Footnote †

'Prefer not to answer' was less than 5%.

Return to footnote referrer

Footnote §

Participants were asked to name a pain-reliever used in the past 30 days instead of whether they used a pain-reliever in the past 30 days. Estimates shown are for opioid pain-relievers or pain-relievers containing opioid(s); over-the-counter medications and other classes (e.g., benzodiazepines) were not included. 18.7% reported 'Prefer not to answer', 17.1% reported 'Do not know' and 3.1% were missing.

Return to footnote § referrer

Note: 'Do not know' was not an option for all questions except those on opioid or opioid-containing pain relievers. Only participants who had ever-used each respective substance were eligible for corresponding questions on past 30-day use.

The average age at first use of each substance type ranged from 13.8 to 17.2 years (Figure 2). On average, participants reported first using cannabis (13.8 years), stimulants (13.8 years), and alcohol (14.0 years) at a younger age compared to other substance types. Stimulants are sometimes prescribed to help with attention or concentration problems, such as Attention Deficit Hyperactivity Disorder (ADHD). Of those who had ever used stimulants, 62.2% had received a formal diagnosis of ADHD. The younger age of initiation for stimulants may be related to use of prescribed stimulant medications for ADHD. Sedatives or tranquilizers are sometimes prescribed to help people sleep, calm them down, or to relax their muscles. Illegal drugs or 'street drugs' (e.g., cocaine, heroin, etc.) cannot be obtained by prescription. The average age of first use was higher for sedatives or hypnotics (16.4 years), illegal drugs (17.0 years), and injected drugs (17.2 years).

Figure 2: Age at initiation of use by substance group for PWLLES participants, September 2021 to February 2023 (n = 442)
Figure #. Text version below.
Figure 2 - Text description
Substance Average age (years) Standard deviation for age (years) Number of participants
Cannabis 13.8 2.8 317
Stimulants 13.8 4.2 180
Alcohol 14.0 3.2 330
Pain relievers 15.6 3.5 158
Sedatives or tranquilizers 16.4 2.8 156
Illegal drugsFootnote § 17.0 2.9 127
Injected drugs 17.2 2.9 35
Footnote §

For the first illegal drug mentioned.

Return to footnote § referrer

Note: Stimulants, pain relievers, and sedatives or tranquilizers included either prescribed or non-prescribed substances. 'Prefer not to answer' and 'Do not know' were excluded from the denominators since missing values could not be used in the calculation of the mean and standard deviation. Ages greater than 1 were included in the denominator. Only participants who had ever used pain-relievers were eligible for answering 'Age at first use of pain-relievers'. Only participants who had ever used sedatives were eligible for answering 'Age at first use of sedatives'. Only participants who had ever used stimulants were eligible for answering 'Age at first use of stimulants'. For all other substances listed, only participants who had used each respective substance in the past 30 days were eligible for answering 'Age at first use'.

Past 30-day binge drinking, defined as 5 drinks or more per occasion for males and 4 drinks or more per occasion for females, was reported by 65.0% of participants who consumed alcohol in the past 30 days. Among those who reported using cannabis in the past 30 days, 35.4% reported using cannabis more than once a day. Furthermore, among those who reported smoking cigarettes in the past 30 days, 70.3% reported smoking cigarettes daily. Of participants who consumed alcohol in the past 30 days, 65.0% reported combining or mixing alcohol with another substance. 51.2% of participants who used cannabis in the past 30 days reported combining or mixing cannabis with another substance. 51.6% of all participants reported combining or mixing tobacco with cannabis.

Substance use behaviours and related harms

Of participants who had used an illegal drug in the past 30 days, the majority (69.6%) reported that it was very easy to obtain an illegal drug (i.e., within 90 minutes). Most (57.0%) stated that they obtained an illegal drug by buying or trading something for it, and nearly 1 quarter (23.7%) said it was given to them by someone.

In the past 30 days, 13.6% stated they had used a drug or substance that was not what they thought it was, 57.0% obtained drug use or preparation equipment, and 45.5% stated they shared drug use or preparation equipment. Approximately 1 in 10 participants (10.2%) reported that they injected a drug in the past 30 days.

Participants most frequently reported that their cannabis or drug use had harmful effects on their:

Impacts in other areas of life (i.e., work, studies, employment, physical health, or relationships) were reported by at least 28.1% of participants (Figure 3).

The most common reported consequences of cannabis or drug use in the past 30 days were:

Figure 3: Harmful effects on various factors due to cannabis or drug use in the past 30 days among PWLLES participants, September 2021 to February 2023 (n = 442)
Figure 3. Text version below.
Figure 3 - Text description
Harmful effects due to cannabis or drug use in the past 30 days Number of participants Percentage of participants (%) Total
Experienced harmful effects due to drug use in the past 30 days
Mental health 164 37.1 442
Finances/ability to meet basic needs 151 34.2 442
Home life, family, or relationships 148 33.5 442
Work, studies, or employment opportunities/security 139 31.4 442
Physical health 138 31.2 442
Friendships or social life 124 28.1 442

Note: Categories were not mutually exclusive.

Driving under the influence was defined as one or more drinks of alcohol within the past hour, using cannabis within the past 2 hours, and using any drug other than alcohol or cannabis within the past hour. Within the past year, driving under the influence of cannabis (15.8%) was more frequently reported than driving under the influence of alcohol (12.9%) or under the influence of other drugs (7.2%). Similarly, being a passenger of a driver under the influence of cannabis (39.8%) was more frequently reported than being a passenger of a driver under the influence of alcohol (32.1%) or under the influence of other drugs (30.8%).

One (1) third of participants (33.0%) reported having overdosed in their lifetime, and of these, the majority (56.2%) had overdosed within the past year. During the most recent overdose, most participants were aware of the drug used (70.5%); however nearly half of all participants (45.9%) were not aware of the potency of the drug used (Figure 4). More than 1 in 5 participants (21.9%) were alone during their most recent overdose. Nearly half of participants (47.9%) reported taking multiple drugs at the same time during their most recent overdose. Participants were asked to name the main drug believed to be responsible for their most recent overdose, where fentanyl was the most commonly reported substance.

Figure 4: Characteristics of most recent overdose experience among PWLLES participants, September 2021 to February 2023 (n = 442)
Figure #. Text version below.
Figure 4 - Text description
Characteristics of recent overdose Number of participants Percentage of participants (%) Total
Aware of drug used for most recent overdose 103 70.5 146
Taking other drugs at the same time during most recent overdose 70 47.9 146
Aware of potency of drug used during most recent overdose 61 41.8 146
Alone during most recent overdose 32 21.9 146

Note: 'Prefer not to answer' was 5.5% for 'Aware of drug used for most recent overdose', 6.2% for 'Taking other drugs at the same time during most recent overdose', 6.2% for 'Aware of potency of drug used during most recent overdose', and 8.2% for 'Alone during most recent overdose'. 'Do not know' was less than 5.0% for 'Aware of drug used for most recent overdose' and 'Taking other drugs at the same time during most recent overdose'. 'Do not know' was 6.2% for 'Aware of potency of drug used during most recent overdose'. 'Do not know' was not an option for 'Alone during most recent overdose'.

Treatment and support

Close to half (42.8%) of the participants reported having ever obtained a naloxone kit. Obtaining a kit in case someone on the streets or at a venue needs it was the main reason reported (37.0% of participants who had ever obtained a naloxone kit). Other reasons for obtaining a kit included (Figure 5):

Figure 5: Main reason for obtaining a naloxone kit among PWLLES participants, September 2021 to February 2023 (n = 442)Footnote
Figure 5. Text version below.
Figure 5 - Text description
Main reason for obtaining naloxone kitFootnote Number of participants Percentage of participants (%) Total
In case someone on the streets or at a venue needs it 70 37.0 189
In case a friend needs it 46 24.3 189
In case you need it for yourself 46 24.3 189
In case someone in your family needs it 17 9.0 189
Other 6 3.2 189
Footnote †

Prefer not to answer was less than 5%.

Return to footnote referrer

Note: 'Do not know' was not an option for Main reason for obtaining naloxone kit. Categories are mutually exclusive.

A similar proportion of participants reported ever feeling that they needed professional help for alcohol, cannabis, and/or drug use (31.9%), as those who have ever sought professional help (32.6%). Among those who reported having ever sought treatment, 38.9% reported seeking professional help in the past 30-days, while 28.5% stated that they were currently trying to get into treatment (including methadone).

Approximately 1 third (30.3%) of participants ever received professional help for alcohol, cannabis, or drug use, where 21.3% voluntarily received professional help and the remaining 9.0% stated that they involuntarily received help (e.g., checked-in by a parent or guardian). Among those who had ever received treatment, 45.5% reported having received professional help in the 30-days prior to survey completion. The most frequently reported types of treatment and supports for those currently receiving treatment were:

With respect to accessing treatment other than alcohol and/or drug treatment, youth have reported seeking a variety of services. The most frequently reported services were (Figure 6):

Figure 6: Services accessed other than alcohol and/or drug treatment among PWLLES participants, September 2021 to February 2023 (n = 442)
Figure 6. Text version below.
Figure 6 - Text description
Services accessed other than alcohol and/or drug treatment Number of participants Percentage of participants (%) Total
Housing services, including shelters 139 31.4 442
Foodbanks or other services offering food security 125 28.3 442
Welfare, disability or other income-support benefits/services 119 26.9 442
Employment services 65 14.7 442
Emergency room treatment 46 10.4 442
Legal services 44 10.0 442
Education or training 38 8.6 442
Childcare 12 2.7 442

Note: Categories were not mutually exclusive.

Limitations

  1. The survey results are not generalizable to the general Canadian population.
  2. Recruitment difficulties due to reduced staffing during the COVID-19 pandemic, Hurricane Fiona in Atlantic Canada, and the general logistics of engaging with the hard-to-reach population of street-involved youth may have contributed to low response rates. As a result, sampling may not capture differences between sentinel sites in a region, and prevalence estimates may not be representative of the street-involved youth population.
  3. The data collection process may have led to engagement issues for some respondents (e.g., questionnaire was too long or repetitive, respondents did not want their responses audio recorded). This, in turn, affected low completion rates.
  4. Recall errors when self-reporting on past drug use (i.e., recall bias) or answering in a way to minimize drug use behaviors due to stigma (i.e., social desirability bias) may have contributed to underreporting of substance use prevalence.
  5. Impacts of the COVID-19 pandemic (e.g., economic stress, social isolation, reduced access to drug treatment services) may have influenced substance use among street-involved youth.
  6. The sample size of this survey was not large enough to perform statistical tests on the results.
  7. The estimate of participants currently attending a school, college, CEGEP or university may have been influenced by the significant number of participants that completed the survey during the summer months when school was not in session.

Technical Notes

Acknowledgements

We would like to acknowledge and thank the contributions of the street-involved youth who shared their experiences as part of the PWLLES. The PWLLES was possible due to the collaboration between 16 centres across Canada that serve street-involved youth and the Office of Drug Research and Surveillance at Health Canada.

References

Reference 1

Adlaf EM, Zdanowicz YM. A cluster-analytic study of substance problems and mental health among street youths. Am J Drug Alcohol Abuse. 1999 Nov;25(4):639-60. doi: 10.1081/ada-100101884. PMID: 10548440.

Return to reference 1

Reference 2

Boivin, J. F., Roy, E., Haley, N., & Galbaud du Fort, G. (2005). The health of street youth: a Canadian Perspective. Canadian Journal of Public Health, 96(6), 432-437.

Return to reference 2

Reference 3

Kirst, M., Erickson, P. G., & Strike, C. (2009). Poly-substance use among female and male street youth in Toronto. International Journal of Social Inquiry, 2(2), 123-139.

Return to reference 3

Reference 4

Kirst, M., Frederick, T., & Erickson, P. G. (2011). Concurrent mental health and substance use problems among street-involved youth. International Journal of Mental Health and Addiction, 9(4), 347-364.

Return to reference 4

Reference 5

Roy, E., Haley, N., Leclerc, P., Sochanski, B. Boudreau, J. F., & Boivin, J. F. (2004). Mortality in a cohort of street youth in Montreal. Journal of the American Medical Association, 292(5), 569-574.

Return to reference 5

Reference 6

Kirst M., Erickson P. Substance use & mental health problems among street-involved youth: The need for a harm reduction approach. Homeless Hub. https://www.homelesshub.ca/sites/default/files/11KIRSTweb.pdf

Return to reference 6

Reference 7

Government of Canada (2021). Visible minority of person. Government of Canada, Statistics Canada. https://www23.statcan.gc.ca/imdb/p3Var.pl?Function=DEC&Id=45152

Return to reference 7

Page details

Date modified: